Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-57.59%
operating margin TTM
-60.48%
revenue TTM
1.25 Billion
revenue per share TTM
6.66$
valuation ratios | |
|---|---|
| pe ratio | -2.74 |
| peg ratio | 0.01 |
| price to book ratio | 1.46 |
| price to sales ratio | 3.19 |
| enterprise value multiple | -4.45 |
| price fair value | 1.46 |
profitability ratios | |
|---|---|
| gross profit margin | 80.28% |
| operating profit margin | -60.48% |
| pretax profit margin | -59.48% |
| net profit margin | -57.59% |
| return on assets | -16.7% |
| return on equity | -44.72% |
| return on capital employed | -42.21% |
liquidity ratio | |
|---|---|
| current ratio | 0.94 |
| quick ratio | 0.72 |
| cash ratio | 0.25 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 806.05 |
| operating cycle | 1,141.93 |
| days of payables outstanding | 327.67 |
| cash conversion cycle | 814.26 |
| receivables turnover | 1.09 |
| payables turnover | 1.11 |
| inventory turnover | 0.45 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.37 |
| debt equity ratio | 1.17 |
| long term debt to capitalization | 0.21 |
| total debt to capitalization | 0.54 |
| interest coverage | -17.75 |
| cash flow to debt ratio | 0.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.00 |
| cash per share | 2.39 |
| operating cash flow per share | 0.00 |
| free cash flow operating cash flow ratio | 0.00 |
| cash flow coverage ratios | 0.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time YS Biopharma Co., Ltd. (NASDAQ:YS) reported earnings?
YS Biopharma Co., Ltd. (YS) published its most recent earnings results on 22-01-2024.
What is YS Biopharma Co., Ltd.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. YS Biopharma Co., Ltd. (NASDAQ:YS)'s trailing twelve months ROE is -44.72%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. YS Biopharma Co., Ltd. (YS) currently has a ROA of -16.7%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did YS's net profit margin stand at?
YS reported a profit margin of -57.59% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is YS's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.94 in the most recent quarter. The quick ratio stood at 0.72, with a Debt/Eq ratio of 1.17.